With new transcatheter options for the repair or replacement of tricuspid valves, the role and timing of repair — whether surgical or minimally invasive — is entering a time of transition.

The tricuspid valve is anatomically complex. It’s often called the “forgotten valve” because of its position in the back of ...

the Evoque tricuspid valve replacement system in February 2024 and the TriClip transcatheter edge-to-edge repair (TEER) device in April 2024. A slate of other devices, such as the Pascal and ...

CMS recently proposed a National Coverage Determination for transcatheter tricuspid valve replacement that -- unlike the more established transcatheter aortic valve replacement (TAVR ...

Southlake is the second hospital in Ontario and one of the first four hospitals in Canada to use this technology, after ...

Older Vermonters are finding a better quality of life thanks to a new heart valve procedure.Last year, Hazel Winter of ...

Moderate-to-severe tricuspid regurgitation (TR) has a high prevalence in the general population, 1 and it progressively increases in older individuals, in whom it is close to 4%.

As tools become more precise and non-invasive, doctors are able to diagnose and treat heart conditions with greater accuracy ...

The U.S. national coverage analysis for transcatheter tricuspid valve replacement drew support from cardiologists and device makers alike, but the Medical Device Manufacturers Association is urging ...

Two patients at MedStar Union Memorial Hospital receive recently FDA-approved Evoque Tricuspid Valve Replacements for severe tricuspid regurgitation. BALTIMORE, Jan. 24, 2025 /PRNewswire/ -- In ...

In medical devices, fourth-quarter sales were up 14%, to $5.05 billion—driven in part by the launch of TriClip, following its approval by the FDA for tricuspid valve repair in April 2024.